NCT06517017 2025-11-28
UltraFrailMM
University of Utah
Phase 2 Recruiting
Clinical Trials
3 trialsNCT01729091 2025-05-09
Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01553357 2012-03-14
Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia
IRCCS Centro di Riferimento Oncologico della Basilicata
Phase 2 Completed